bodyType

customContents

entityId

entityUuid

articlePageQuery

filter

article

articleBaseAdvertisingInfoArticle

articleListArticle

articleSeoArticle

helpersCheckIsPostiesArticle

hooksArticleAcknowledgementGateOverlayArticle

hooksTrackPageViewArticle

hooksContentInterestArticle

articleLinkingDataContent

articleSchemaContent

liveArticle

advertZone

sentiment

contentLock

topics

types

sections

moreOnThisArticles

urlAlias

commentCount

sponsorType

authorLocations

authors

paywallTypes

corrections

displaySlideShow

multimediaEmbed

printHeadline

seriesContainer

socialHeadline

headline

flag

firstTopic

glossary

flattenTypeIds

publishedDate

additionalInfoBoxes

images

image

relatedLinks

relatedNewsletters

__typename

createdDate

sponsor

factSheets

series

disableOffPlatformContent

published

updatedDate

summary

subHeadline

body

keywords

copyrighted

customTimezone

liveContents

Stephen Chen

A coronavirus strain isolated in India carried a mutation that could upend vaccine development around the globe, according to researchers from Australia and Taiwan.
The non-peer reviewed study said the change had occurred in part of the spike protein that allows the virus to bind with certain human cells.
This structure targets cells containing ACE2, an enzyme found in the lungs which also allowed the severe acute respiratory syndrome (Sars) virus to infect people.
Scientists know more about this receptor than any other so had been working on antibodies that target it, but an unexpected structural change could render them useless.


The researchers – led by Wei-Lung Wang, from the National Changhua University of Education in Taiwan, and collaborators from Murdoch University in Australia – said this was the first report of a significant mutation that could threaten development of a vaccine for the virus that causes Covid-19.
“The observation of this study raised the alarm that Sars-CoV-2 mutation with varied epitope [something an antibody attaches itself to] profile could arise at any time,” they wrote in a paper released on preprint review site biorxiv.org on Saturday.
“[This] means current vaccine development against Sars-CoV-2 is at great risk of becoming futile.”
Although the strain in question was first sampled by the National Institute of Virology from a patient in Kerala as early as January, the full genome sequence was only released to the international community last month – a delay that raised eyebrows among some researchers.


The patient was said to be a medical student returning from Wuhan, but the strain does not appear to be closely related to any of those identified in the Chinese city and appears to be an outlier compared with variants recorded in other countries.
The researchers found that the mutation occurred in the spike protein’s receptor-binding domain (RBD).
A computer simulation shows that the RBD mutation, which was not found in other variants across the globe, could remove a hydrogen bond from the spike protein.
Without this bond, the virus may be less likely to bind with ACE2, or angiotensin converting enzyme-2, which is found in the lungs and other organs.
Coronavirus: US researchers develop possible vaccine with novel injection technology
Since its first confirmed identification in early January, the virus has reached every continent except for Antarctica with more than 3,500 mutations detected, according to the China National Centre for Bioinformation.
For a long time India appeared to have been spared by the Covid-19 pandemic, but it has now recorded around 9,000 confirmed cases.


The virus’s presence in the country has grown rapidly in recent weeks, with cases being identified in crowded slum areas, and scientists fear the world’s second biggest country could see the next major outbreak – something that threatens a humanitarian disaster.
The international community still knows relatively little about the evolution and spread of the virus due to limited testing and information from the subcontinent.
A researcher with the Chinese Academy of Sciences in Beijing who is tracking the mutation of the coronavirus said he was closely monitoring the emerging strains from India.
Volunteers needed for second phase of China coronavirus vaccine trial
Some vaccines have already started clinical trials in China and the US, but the RDB mutation could create more uncertainty about the eventual outcome.
The findings of the new study, which was not peer-reviewed, will need further verification. For instance, there was a possibility that the mutation was caused by a technical error during the sequencing process, according to the researcher, who requested not to be named due to the sensitivity of the issue.


He also said the results produced by the computer simulation may be misleading.
“Laboratory experiments will be needed to verify whether the protein changes in real life,” said the researcher.
Benjamin Neuman, professor and chair of biological sciences with the Texas A&M University in Texarkana, said the mutation appeared to be random, not the result of natural selection by the immune system because there were no more variants in that part of the spike than elsewhere in the genome.
He also agreed that the computer modeling might need improvement. "The mutation could make a small difference in binding affinity, though the actual effect of this mutation would be difficult to predict and would be better tested experimentally," Neuman said.
The constant mutation of the coronavirus means the vaccine will need periodic tests and updates. "The influenza virus mutates constantly, and at about the same rate as coronavirus, but we are able to successfully vaccinate against this moving target," he said. "Finding a vaccine strategy that actually works in people is the difficult part."
The unusual behaviour of the coronavirus has kept scientists around the world scratching their heads. For instance, it has infected a large number of patients around the world but the genetic structure of the strain has remained relatively stable.
Chinese military scientists hope to test coronavirus vaccine abroad
Some researchers have speculated that it might have been spreading quietly in humans for a long time and evolved to a form that did not require too many changes to adapt to different environments and populations.
But others worry the thousands of strains sampled and sequenced are just the tip of the iceberg – and greater variety increases the risk that new strains will require new vaccines in the same way the flu virus does.
Although China has five different vaccines under development “it is impossible to predict which one is more likely to succeed”, said the researcher. “They could all end in failure.”

Sign up now and get a 10% discount (original price US$400) off the China AI Report 2020 by SCMP Research. Learn about the AI ambitions of Alibaba, Baidu & JD.com through our in-depth case studies, and explore new applications of AI across industries. The report also includes exclusive access to webinars to interact with C-level executives from leading China AI companies (via live Q&A sessions). Offer valid until 31 May 2020.



How long Covid still keeps lives on hold 5 years after the pandemic began

Canada’s finance minister quits as unpopular Trudeau faces biggest test of political career

Xi puts faith in Lee to deliver on Hong Kong economic development, reform

China’s dwindling Western expat workforce should be cause for concern

Coronavirus pandemic

Coronavirus mutation could threaten the race to develop vaccine

The viral strain identified in India contains a mutation that could undermine current efforts to develop a vaccine. Photo: AP

China developing 9 potential vaccines in global race for coronavirus cure

CanSino is recruiting healthy volunteers for a clinical trial of its vaccine candidate. Photo: Weibo

David Ho, the man who tamed Aids, in race to find coronavirus vaccine

A transmission electron microscope image of an isolate from the first US case of Covid-19, with viral particles in blue. Photo: Getty Images

-ONE TIME USE ONLY-Alejandro Chavez, center, with doctoral students Samuel Resnick and Debbie Hong.[12APRIL2020 FEATURE POST MAGAZINE]CREDIT: Bloomberg / Samantha Casolari

Yaoxing Huang, David Ho, and Sho Iketani.

YAOUNDE, CAMEROON - JULY 28: Mat Lebreton and Cyrille Djoko examine a bat as part of their search for dangerous animal pathogens in the Global Viral Forecasting Initiative Lab in Yaounde, Cameroon, July 28, 2011. Both scientists work with Dr Nathan D. Wolfe, an American virologist who is the Director of the Global Viral Forecasting Initiative and the Lorry I. Lokey Visiting Professor in Human Biology at Stanford University. Dr. Wolfe spent over eight years conducting biomedical research in both sub-Saharan Africa and Southeast Asia. In 2007, he founded the Global Viral Forecasting Initiative with the goal of developing an early warning system for pandemics to monitor the transmission of infectious diseases from animals to humans. The initiative currently coordinates a staff of over 100 scientists in China, Cameroon, Equatorial Guinea, DR Congo, PR Congo, Lao, Gabon, Central African Republic, Malaysia, Madagascar and Sao Tome. He also directs Global Viral Forecasting Inc. which offers b

Handout Image of Zhi Hong, chief executive officer of Brii Biosciences.[12APRIL2020 FEATURE POST MAGAZINE]

A man wears a face mask while he visits Times Square as rain falls on March 28, 2020 in New York City. - US President Donald Trump said on March 28, 2020 that he's considering a short-term quarantine of New York state, New Jersey, and parts of Connecticut. (Photo by Kena Betancur / AFP)

David Ho, Time Magazine person of the year 1996.[12APRIL2020 FEATURE POST MAGAZINE] CREDIT: Time Magazine

Coronavirus could attack immune system like HIV by targeting protective cells, warn scientists

T-cells attack harmful cells, such as cancers. Photo: Shutterstock

The study suggests coronavirus can infect T cells. Photo: Shutterstock

Coronavirus that causes Covid-19 can produce more than three times as many pathogens than Sars strain, HKU study reveals

Microbiologist Yuen Kwok-yung suggested appointing an infection-control supervisor in each office and school of Hong Kong. Photo: Oliver Tsang

Professor Yuen Kwok-yung, Chairperson of Infectious Diseases from HKU, attends a press conference at the Queen Mary Hospital in Pok Fu Lam. 11APR20 SCMP / Edmond So

How long will a coronavirus vaccine take? A Q&A with Jerome Kim, head of the International Vaccine Institute

A microbiologist carries out Covid-19 research in Athens, Greece, on April 6, 2020. Photo: EPA-EFE

In this Wednesday, April 8, 2020 photo provided by the Center for Pharmaceutical Research, a participant in a COVID-19 coronavirus vaccine trial receives an injection in Kansas City, Mo. This early safety study, called a Phase 1 trial, is using a vaccine candidate developed by Inovio Pharmaceuticals. (Center for Pharmaceutical Research via AP)

In this Wednesday, April 8, 2020 photo provided by the Center for Pharmaceutical Research, a pharmacy technologist using a biosafety level 2 hood prepares a COVID-19 coronavirus vaccine candidate for testing in Kansas City, Mo. This early safety study, called a Phase 1 trial, is using a vaccine candidate developed by Inovio Pharmaceuticals. (Center for Pharmaceutical Research via AP)

Jerome H Kim

A researcher works on virus replication in order to development a vaccine against the coronavirus Covid-19, in Belo Horizonte, state of Minas Gerais, Brazil, on March 26, 2020. - The Ministry of Health convened The Technological Vaccine Center of the Federal University of Minas Gerais laboratory to conduct research on the coronavirus COVID-19 in order to diagnose, test and develop a vaccine. (Photo by Douglas MAGNO / AFP)

A researcher works in a lab at the Duke-NUS Medical School, which is developing a way to track genetic changes that speed testing of vaccines against the coronavirus disease (COVID-19), in Singapore March 23, 2020. Picture taken March 23, 2020. REUTERS/Joseph Campbell

News

China

Science

Coronavirus

Asia


A strain found in India showed changes in the mechanism used to bind the virus to human cells which could render current research futile
Researchers are targeting the same process that allowed Sars to infect people, but the mutation could upend their assumptions



Researchers are targeting the same process that allowed Sars to infect people, but a strain found in India could upend their assumptions.


Coronavirus mutation could threaten the race to develop vaccine

A strain found in India showed changes in the mechanism used to bind the virus to human cells which could render current research futile Researchers are targeting the same process that allowed Sars to infect people, but the mutation could upend their assumptions

A strain found in India showed changes in the mechanism used to bind the virus to human cells which could render current research futile

Researchers are targeting the same process that allowed Sars to infect people, but the mutation could upend their assumptions